Nanoparticles-loaded nanofiber topical patch of 5-fluorouracil: fabrication, characterization, and preclinical assessment in skin cancer
Source abstract
Abstract
Skin cancer is the uncontrolled proliferation of abnormal skin cells. It is mostly caused by unrepaired deoxyribonucleic acid (DNA) damage to skin cells, which results in mutations, or genetic flaws, that cause skin cells to reproduce rapidly and develop malignant tumors. This study aimed to develop and analyze nanoparticle-loaded multilayered nanofibers (M-NFs) for the treatment of skin cancer. 5-Fluorouracil (5-FU) was chosen as the chemotherapy medication. Poly (D, L-lactic-co-glycolic acid) (PLGA) nanoparticles were created utilizing a double emulsion technique. The 25-2 fractional factorial design was used to test a variety of process and formulation parameters. The resultant nanoparticles were assessed for zeta potential, entrapment efficiency, particle size, shape. The optimized drug-loaded PLGA nanoparticle had a particle size of 178.4 ± 6.1 nm, a zeta potential of −28.2 mV, and an entrapment efficiency of 86.12% ± 2.1%. Transmission electron microscopy images showed uniformly sized spherical particles. Additional drug-loaded PLGA nanoparticles were integrated into M-NFs. The produced nanofibers were thoroughly characterized, and comparative in-vitro drug diffusion tests were conducted. In-vitro drug diffusion studies of drug-loaded PLGA nanoparticles into M-NFs demonstrated regulated release for up to 7 d. Further in-vivo effectiveness, histopathology, and immunohistochemistry studies were performed on SCID mice. According to the findings, the growth of skin cancer tumors has been steadily reduced, indicating that there are effective treatments for skin cancer. Developed multilayered electrospun nanofiber system demonstrates superior sustained release, enhanced drug localization, and improved cytotoxic efficacy compared to conventional nanofiber-only or nanoparticle-only formulations. This addition effectively underscores the novelty and therapeutic advantage of our integrated delivery platform.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Curcumin's Biomedical Applications · Advancements in Transdermal Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology
Department of Pharmaceutical Technology, LJ Institute of Pharmacy, LJK University, LJ Campus, Near Sarkhej-Sanand Circle
Funding
Charotar University of Science and Technology · CHARUSAT SEED Grant for Research
References (37)
Show source-provided references
1. 10.1016/j.ejca.2015.06.11010.1016/j.ejca.2015.06.110 ↗
2. 10.2174/187221051366619031409564310.2174/1872210513666190314095643 ↗
3. 10.4414/smw.2020.2037510.4414/smw.2020.20375 ↗
4. Leelakanok N. Fabrication and characterization of 5-Fu loaded poly (lactide-Co-Glycolide) millirods: assessment of their suitability for local tumor treatment [Doctoral dissertation]. Iowa City (IA): The University of Iowa.
5. 10.1007/s13204-018-0830-910.1007/s13204-018-0830-9 ↗
6. 10.1016/j.ijbiomac.2020.07.12610.1016/j.ijbiomac.2020.07.126 ↗
7. 10.1016/B978-0-12-813663-8.00004-X10.1016/B978-0-12-813663-8.00004-X ↗
8. 10.1186/s12951-025-03438-310.1186/s12951-025-03438-3 ↗
9. Nair KL, Jagadeeshan S, Nair SA, et al. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Int J Nanomed. 2011;17:1685–1697.
10. 10.1590/s2175-9790201800000100610.1590/s2175-97902018000001006 ↗
11. 10.1016/j.tice.2024.10260610.1016/j.tice.2024.102606 ↗
12. 10.1038/s41598-020-57666-810.1038/s41598-020-57666-8 ↗
13. 10.1016/j.jfoodeng.2011.10.02510.1016/j.jfoodeng.2011.10.025 ↗
14. 10.1016/j.saa.2022.12229110.1016/j.saa.2022.122291 ↗
15. 10.3390/biom1101010910.3390/biom11010109 ↗
16. 10.1007/s10856-013-4926-110.1007/s10856-013-4926-1 ↗
17. 10.1016/j.ijbiomac.2020.06.24010.1016/j.ijbiomac.2020.06.240 ↗
18. 10.1016/j.apsusc.2020.14546210.1016/j.apsusc.2020.145462 ↗
19. 10.3390/polym1211248610.3390/polym12112486 ↗
20. 10.1016/j.jddst.2023.10458210.1016/j.jddst.2023.104582 ↗
21. 10.1016/j.carbpol.2020.11587310.1016/j.carbpol.2020.115873 ↗
22. 10.1039/D0NJ01594F10.1039/D0NJ01594F ↗
23. 10.1038/s41467-022-32804-010.1038/s41467-022-32804-0 ↗
24. 10.1007/s11814-008-0151-x10.1007/s11814-008-0151-x ↗
25. 10.1080/21691401.2018.143069810.1080/21691401.2018.1430698 ↗
26. 10.1007/s12668-019-00627-x10.1007/s12668-019-00627-x ↗
27. 10.2174/138161282166615030215195910.2174/1381612821666150302151959 ↗
28. 10.1016/j.ejps.2019.10500210.1016/j.ejps.2019.105002 ↗
29. 10.1002/adfm.20211122810.1002/adfm.202111228 ↗
30. 10.1126/sciadv.abc203610.1126/sciadv.abc2036 ↗
31. 10.1016/j.scib.2017.11.01810.1016/j.scib.2017.11.018 ↗
32. 10.1016/j.canlet.2014.11.00110.1016/j.canlet.2014.11.001 ↗
33. 10.29252/jmp.1.73.2710.29252/jmp.1.73.27 ↗
34. 10.3390/molecules2408151610.3390/molecules24081516 ↗
35. 10.1111/j.1365-4632.2010.04474.x10.1111/j.1365-4632.2010.04474.x ↗
36. De Wet J, Steyn M, Jordaan HF, et al. An analysis of biopsies for suspected skin cancer at a tertiary care dermatology clinic in the western Cape province of south Africa. J Skin Cancer. 2020;2020(1):9061532.
37. Pérez LL, Bashline B. Skin cancer: prevention. FP Essent. 2019;481:28–31.